Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report
- PMID: 3852685
- DOI: 10.1007/BF00320726
Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report
Abstract
Acquired amegakaryocytic thrombocytopenic purpura is a rare disease. Most reported patients did not respond to any therapeutical approach. Recently we observed a striking improvement of this disorder in a female patient shortly after therapy with danazol had been initiated. This observation and its possible implication for the treatment of amegakaryocytic thrombocytopenia are reported herein.